For the quarter ending 2025-12-31, TWST made $103,698K in revenue. -$30,451K in net income. Net profit margin of -29.37%.
| Income Statement | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 |
|---|---|---|---|---|
| Revenues | 103,698 | 99,009 | 96,057 | 92,793 |
| Cost of revenues | 49,726 | 48,172 | 44,760 | 46,765 |
| Research and development expenses | 17,130 | 17,014 | 18,047 | 23,917 |
| Selling, general and administrative expenses | 69,742 | 63,758 | 63,370 | 63,671 |
| Restructuring and other costs | - | 0 | - | - |
| Change in fair value of contingent considerations and holdbacks | - | 0 | - | - |
| Impairment of long-lived assets | - | 0 | 0 | - |
| Total costs and expenses | 136,598 | 128,944 | 126,177 | 134,353 |
| Loss from operations | -32,900 | -29,935 | -30,120 | -41,560 |
| Gain on sale of business | - | 0 | 48,847 | - |
| Interest income | 2,175 | 2,633 | 2,690 | 2,801 |
| Interest expense | - | - | - | 143 |
| Other income (expense), net | 471 | 253 | -836 | -251 |
| Loss before income taxes | -30,254 | -26,882 | 20,581 | -39,153 |
| Income tax expense | 253 | 253 | 191 | 175 |
| Net loss | -30,507 | -27,138 | 20,390 | -39,328 |
| Change in unrealized gain (loss) on investments | 18 | 11 | -25 | 30 |
| Foreign currency translation adjustment | 38 | 208 | -177 | -25 |
| Comprehensive loss | -30,451 | -26,919 | 20,188 | -39,323 |
| Net loss per share, basic (in usd per share) | -0.5 | -0.45 | 0.34 | -0.66 |
| Net loss per share, diluted (in usd per share) | -0.5 | -0.44 | 0.33 | -0.66 |
| Weighted average shares used in computing net loss per share basic (in shares) | 61,080,000 | -118,998,000 | 59,995,000 | 59,649,000 |
| Weighted average shares used in computing net loss per share diluted (in shares) | 61,080,000 | -120,167,000 | 61,164,000 | 59,649,000 |
Twist Bioscience Corp (TWST)
Twist Bioscience Corp (TWST)